Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adherence and Persistence to Tocilizumab in RA
NCT01010503Phase 4Completed
- Sponsor
- Roche
- Start
- Jun 2009
- Primary completion
- May 2010
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 4 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Roche. Started Jun 2009; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01010503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01010503.